Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 12 Relevant Journals, 195 Conferences Proceeding, 14 National Symposium are presently dedicated exclusively to Hyperglycemia and about 48 articles are being published on Hyperglycemia.
Hyperglycemia is the technical term for high blood glucose (blood sugar). High blood glucose happens when the body has too little insulin or when the body can't use insulin properly. Temporary hyperglycemia is often benign and asymptomatic. Blood glucose levels can rise well above normal for significant periods without producing any permanent effects or symptoms. However, chronic hyperglycemia at levels more than slightly above normal can produce a very wide variety of serious complications over a period of years, including kidney damage, neurological damage, cardiovascular damage, damage to the retina or damage to feet and legs. Diabetic neuropathy may be a result of long-term hyperglycemia.
Hyperglycemia can be a serious problem if not treated in time. In untreated hyperglycemia, a condition called ketoacidosis (contrast ketosis) could occur. Ketoacidosis develops when the body does not have enough insulin. Without insulin, the body isn't able to utilize the glucose for fuel, so the body starts to break down fats for energy. Ketoacidosis is a life-threatening condition which needs immediate treatment. Symptoms include: shortness of breath, breath that smells fruity (such as pear drops), nausea and vomiting, and very dry mouth. Chronic hyperglycemia (high blood sugar) injures the heart in patients without a history of heart disease or diabetes and is strongly associated with heart attacks and death in subjects with no coronary heart disease or history of heart failure.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance
This conference is aimed to give each and every detailed score about the scientific traditionalism and optimism to the citizen and consumer to remain aware of Hyperglycemia. Scientist will also give fruitful information about various acute or chronic Hyperglycemia like Polyphagia, Polydipsia, Blurred vision, Fatigue (sleepiness), Erectile dysfunction, Cardiac arrhythmia, Stupor, Coma, Seizures
ConferenceSeries Cordially invites, Doctors, surgeons, researchers, and other health-care professionals, scientists and students working in the field across the globe to participate in the Hyperglycemia conference, where all the recent advancement and researches in the field of Hyperglycemia will be discussed under a single roof. Hyperglycemia will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field. It is open to all types of research methodologies both from academia and industry.
Diabetes currently affects more than 382 million people worldwide and is expected to affect 592 million by 2035. 29.1 million Americans (9.3% of the population) have diabetes (both types) and as many as 2.5 million Americans currently live with type 1, insulin-dependent diabetes. 86 million Americans aged 20 or older are classified as prediabetic, including 51% of those aged 65 or older. Diabetes results in $245 billion annual U.S. healthcare costs, growing 8% each year and driven by complications of poor glucose control. Worldwide, costs of diabetes are estimated to account for 11% of total healthcare expenditures. Nearly 1 in every 400 children in the U.S. has type 1 diabetes and is insulin-dependent.26% of the U.S. population aged 65 or older has diabetes.
Diabetes is a major cause of heart disease, stroke, kidney disease, blindness, and numerous other debilitating diseases and afflictions. It is the seventh leading cause of death in the U.S.
Blood glucose monitoring device market is a very lucrative market with a huge growth potential in coming years. Increasing incidence of people suffering from diabetes, convenience of continuous glucose monitoring over conventional monitoring, early detection of Hypo and Hyperglycemic diabetes and increasing technological innovations are the driving factors for the market to grow. There are many types of blood glucose level monitors on the market today, ranging in price, and ease of use, size, portability, and length of testing time. However, market is constrained by high cost associated with the diagnosis and monitoring of the disease, reimbursement issues and patent expiry.
Global glucose monitoring device market is segmented by blood glucose meters, blood glucose testing strips, lancets, continuous glucose monitoring devices and by geography into North America, Europe, and Asia-Pacific etc. US are the major market share holder for the test strips market while China has the highest number of self- monitoring blood glucose device users. . 4 companies Roche Diagnostic, Life Scan Inc., Bayer HealthCare and Abbott Laboratories together controls nearly 50% market share of self-monitoring blood glucose devices. Asia-Pacific and Europe are estimated to show increased market share in coming years because of more people suffering from diabetes and continuous innovations in technology. North America accounts for 40% of the market share followed by Europe and Asia-Pacific.
Relevant Society and Associations
This page will be updated regularly.
This page was last updated on October 26, 2021